| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 420.52▼ | 421.73▼ | 421.58▼ | 422.69▼ | 418.37▲ |
| MA10 | 420.86▼ | 422.23▼ | 422.86▼ | 421.72▼ | 405.47▲ |
| MA20 | 421.24▼ | 423.63▼ | 423.83▼ | 418.23▲ | 418.08▲ |
| MA50 | 422.48▼ | 423.66▼ | 422.18▼ | 403.73▲ | 442.28▼ |
| MA100 | 422.85▼ | 422.00▼ | 421.94▼ | 420.14▲ | 445.68▼ |
| MA200 | 423.65▼ | 421.07▼ | 413.93▲ | 445.66▼ | 375.61▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.092▼ | -0.385▼ | -0.699▼ | -0.495▼ | 3.942▲ |
| RSI | 39.011▼ | 45.045▼ | 44.651▼ | 55.506▲ | 48.658▼ |
| STOCH | 34.927 | 60.602 | 60.310 | 52.642 | 74.482 |
| WILL %R | -66.534 | -43.079 | -39.618 | -42.061 | -47.858 |
| CCI | -89.210 | -59.036 | -67.818 | -39.346 | 97.191 |
|
Tuesday, November 04, 2025 07:33 AM
US biopharma Vertex Pharmaceuticals has reported consolidated financial results for the third quarter of 2025 and refined its full year financial guidance.
|
|
Tuesday, November 04, 2025 06:39 AM
Baystreet.ca News Commentary – The global biologics industry is experiencing unprecedented expansion as the market surges toward $679.56 billion by 2030[1] driven by precision ...
|
|
Tuesday, November 04, 2025 06:39 AM
Baystreet.ca News Commentary – The global biologics industry is experiencing unprecedented expansion as the market surges toward $679.56 billion by 2030[1] driven by precision ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/11/25 | 417.54 | 427.25 | 411.025 | 420.31 | 685,503 |
| 04/11/25 | 418.55 | 430.71 | 403.16 | 421.67 | 2,286,908 |
| 03/11/25 | 428.48 | 430.10 | 418.60 | 426.00 | 1,937,700 |
| 31/10/25 | 416.28 | 426.96 | 415.76 | 425.57 | 1,499,100 |
| 30/10/25 | 417.19 | 422.95 | 415.00 | 419.89 | 1,233,600 |
| 29/10/25 | 418.02 | 422.98 | 415.77 | 417.21 | 1,320,725 |
| 28/10/25 | 418.00 | 422.57 | 417.39 | 422.39 | 1,219,078 |
| 27/10/25 | 422.00 | 423.61 | 418.76 | 420.17 | 1,261,800 |
| 24/10/25 | 423.41 | 425.86 | 420.60 | 421.39 | 1,004,900 |
| 23/10/25 | 427.85 | 432.76 | 421.26 | 422.63 | 1,760,900 |
|
|
||||
|
|
||||
|
|